News

Scientists have genetically engineered bacteria to produce molecules that have the potential to treat certain disorders by altering human metabolism.

Study shows an experimental drug from tick saliva may hold promise as a treatment for HIV-linked heart disease.

Two different, but highly-connected areas necessary for encoding the value and availability of a reward have been identified.

Imperial scientists have developed algorithms for successful automated whole cell patch clamp of neurons in vivo.

Online game players are being asked to design an RNA molecule capable of acting as an on/off switch for the gene-editing tool CRISPR/Cas9.

The chip is being designed to provide real-time monitoring of vascular cell well-being and nutrient circulation across the barrier between mother and fetus, and under the influences of the malaria parasite to see how it responds to various drug treatments.

A new “anatomic atlas” of how B cells – the immune system’s producer of antibodies – link up to form networks has been charted.

Researchers from the University of Bern propose the "alternate import model" of tRNAs, which could help lead to the development of drugs for diseases such as sleeping sickness.

UNC researchers identify two proteins – MMP-9 and HDAC6 – that help promote this harmful, amyloid-to-inflammation-to-tau cascade.

The LAMP test can detect meningococcal disease in under an hour, which could lead to faster diagnosis and treatment for patients.